These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Non-sirtuin histone deacetylases in the control of cardiac aging. Ferguson BS, McKinsey TA. J Mol Cell Cardiol; 2015 Jun 01; 83():14-20. PubMed ID: 25791169 [Abstract] [Full Text] [Related]
13. Adipose-Muscle crosstalk in age-related metabolic disorders: The emerging roles of adipo-myokines. Fang P, She Y, Yu M, Min W, Shang W, Zhang Z. Ageing Res Rev; 2023 Feb 01; 84():101829. PubMed ID: 36563906 [Abstract] [Full Text] [Related]
14. Determination of protein lysine deacetylation. Ellis DJP, Yuan Z, Seto E. Curr Protoc Protein Sci; 2008 Nov 01; Chapter 14():14.12.1-14.12.14. PubMed ID: 19016433 [Abstract] [Full Text] [Related]
15. Acute inhibition of protein deacetylases does not impact skeletal muscle insulin action. Martins VF, Begur M, Lakkaraju S, Svensson K, Park J, Hetrick B, McCurdy CE, Schenk S. Am J Physiol Cell Physiol; 2019 Nov 01; 317(5):C964-C968. PubMed ID: 31461343 [Abstract] [Full Text] [Related]
18. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). Lawson M, Uciechowska U, Schemies J, Rumpf T, Jung M, Sippl W. Biochim Biophys Acta; 2010 Nov 01; 1799(10-12):726-39. PubMed ID: 20601279 [Abstract] [Full Text] [Related]
19. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Bai G, Wei D, Zou S, Ren K, Dubner R. Mol Pain; 2010 Sep 07; 6():51. PubMed ID: 20822541 [Abstract] [Full Text] [Related]
20. Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies. Sandonà M, Cavioli G, Renzini A, Cedola A, Gigli G, Coletti D, McKinsey TA, Moresi V, Saccone V. Int J Mol Sci; 2023 Feb 21; 24(5):. PubMed ID: 36901738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]